-
Cellectar Biosciences, Inc. (NASDAQ:CLRB) Q4 2023 Earnings Call Transcript
28 Mar 2024 15:21 GMT
… at the end of the third quarter (see the details here). … to Cellectar Biosciences 2023 Yearend Earnings Call. Today’s call … Cellectar as the leading pharmaceutical company, as measured by … and applications for radio pharmaceuticals. We also announced promising …
-
GlycoMimetics, Inc. (NASDAQ:GLYC) Q4 2023 Earnings Call Transcript
28 Mar 2024 15:22 GMT
… Inc. (NASDAQ:GLYC) Q4 2023 Earnings Call Transcript March 27, 2024 … at the end of the third quarter (see the details here). … Q4 and Full Year 2023 Earnings Call. At this time, … and EMA, assesses safety, pharmacokinetics and preliminary clinical activity of …
-
PDS Biotechnology Corporation (NASDAQ:PDSB) Q4 2023 Earnings Call Transcript
28 Mar 2024 15:21 GMT
… (NASDAQ:PDSB) Q4 2023 Earnings Call Transcript March 27, 2024 … at the end of the third quarter (see the details here). … years of experience in the pharmaceutical industry. Most recently, Kirk … second or early part of third quarter on where the trial …
-
STRATA Skin Sciences, Inc. (SSKN) Q4 2023 Earnings Call Transcript
28 Mar 2024 02:42 GMT
… 39; Fourth Quarter 2023 Earnings Conference Call and Webcast. … recognition, mentioned in our earnings release, we are confident … have explained in the third quarter earnings call in November, this … changed to different of pharmaceutical companies. So we wanted …
-
BioCardia, Inc. (BCDA) Q4 2023 Earnings Call Transcript
28 Mar 2024 02:43 GMT
BioCardia, Inc. (NASDAQ:BCDA) Q4 2023 Results Conference Call March 27, 2024 4:30 PM ET Company Participants Miranda Peto - Investor Relations
Peter Altman - President and Chief Executive Officer
David McClung - Chief Financial Officer Operator Ladies and …
-
STRATA Skin Sciences Reports Fourth Quarter and Full-Year 2023 Earnings
27 Mar 2024 20:01 GMT
HORSHAM, Pa., March 27, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or “the Company”), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of …
-
Biora Therapeutics, Inc. (NASDAQ:BIOR) Q4 2023 Earnings Call Transcript
27 Mar 2024 16:34 GMT
… (NASDAQ:BIOR) Q4 2023 Earnings Call Transcript March 26, … the safety, and pharmacokinetics and pharmacodynamics including effects on … plasma and tissue pharmacokinetics and pharmacodynamics in UC patients … step forward during the third quarter by reducing on …
-
BioLineRx Ltd. (NASDAQ:BLRX) Q4 2023 Earnings Call Transcript
27 Mar 2024 16:34 GMT
… Ltd. (NASDAQ:BLRX) Q4 2023 Earnings Call Transcript March 26, 2024 … at the end of the third quarter (see the details here). Operator … commercial launches know that institutional pharmacy and therapeutic committees or P …
-
Cintas Reports Upbeat Earnings, Joins PaySign, Noah Holdings And Other Big Stocks Moving Higher On Wednesday
27 Mar 2024 14:57 GMT
… -expected third-quarter financial results and raised FY24 guidance.
Cintas posted GAAP earnings … issued FY25 adjusted earnings guidance above estimates..
Lexicon Pharmaceuticals, Inc. LXRX gained …
-
BioAtla, Inc. (NASDAQ:BCAB) Q4 2023 Earnings Call Transcript
27 Mar 2024 14:12 GMT
… (NASDAQ:BCAB) Q4 2023 Earnings Call Transcript March 26, 2024 … at the end of the third quarter (see the details here). … quarter full year 2023 BioAtla earnings call. BioAtla is the … strategic collaborations with major pharmaceutical partners this year, which …